Differential diagnosis of type 1 diabetes: Which genetic syndromes need to be considered?

Pediatric Diabetes

Volumn 8, Issue SUPPL. 6, 2007, Pages 15-23

  Barrett, Timothy Geoffrey ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Alstrom; Diabetes; Non type 1; Syndrome; Wolfram

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; MITOCHONDRIAL DNA; THIAMINE;

ALSTROM SYNDROME; BARDET BIEDL SYNDROME; CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; GENE FUNCTION; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; GENOTYPE; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; LIPODYSTROPHY; MATURITY ONSET DIABETES MELLITUS; MEGALOBLASTIC ANEMIA; NEWBORN DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; WOLFRAM SYNDROME;

EID: 34548205978     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00278.x     Document Type: Review

References (30)

1. Ehtisham S, Hattersley A, Dunger D, Barrett T; BSPED C linical T rials G roup. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004: 89: 526-529.
2. Haines L, Wan K, Lynn R, Barrett T, Shield J. Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care 2007: 30: 1097-1101.
3. Hattersley A, Pearson ET Minireview: Pharmacogenetics and beyond: the interaction of therapeutic response, β-cell physiology, and genetics in diabetes. Endocrinology 2006: 147: 2657-2663.
4. Raeder H, Johansson S, Holm PI et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2006: 38: 54-62.
5. Frayling TM, Evans JC, Bulman MP et al. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001: 50 (Suppl. 1): 94-100.
6. Stride A, Hattersley AT. Different genes, different diabetes: Lessons from maturity-onset diabetes of the young. Ann Med 2002: 34: 207-216.
7. Stride A, Vaxillaire M, Tuomi T et al. The genetic abnormality in the β cell determines the response to an oral glucose load. Diabetologia 2002: 45: 427-435.
8. Pearson ER, Liddell WG, S hepherd M et al. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000: 17: 543-545.
9. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, H attersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003: 362: 1275-1281.
10. Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1β. Nephrol Dial Transplant 2004: 19: 2703-2708.
11. Gloyn A, Pearson E, Antcliff J et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004: 350: 1838-1849.
12. Flanagan S, Patch A, Mackay D et al. Mutations in KATP channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007; (E publication ahead of print).
13. Pearson E, Flechtner I, Njolstad P et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006: 355: 467-477.
14. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995: 346: 1458-1463.
15. Inoue H, Tanizawa Y, Wasson J et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998: 20: 143-148.
16. Khanim F, Kirk J, Latif F et al. WFS1/Wolframin mutations, Wolfram syndrome and associated diseases. Hum Mutat 2001: 17: 357-367.
17. Cryns K, Sivakumaran T, Van den Ouweland J et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat 2003: 22: 275-287.
18. Senee V, Vattem K, Delepine M et al. Wolcott-Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004: 53: 1876-1883.
19. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000: 25: 406-409.
20. Rogers LE, Porter FS, Sidbury JB. Thiamine-responsive megaloblastic anemia. J Pediatr 1969: 74: 494-504.
21. Valerio G, Franzese A, Poggi V et al. Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. Diabetes Care 1998: 21: 38-41.
22. Labay V, Raz T, Baron D et al. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet 1999: 22: 300-304.
23. Van Den Ouweland J, Lemkes H, Ruitenbeek W et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992: 1: 368-371.
24. Taylor SI, Kadowaki T, Kadowaki H, Accili D, Cama A, Mckeon C. Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care 1990: 13: 257-279.
25. Alström CH, Hallgren B, Nilsson LB, Asander H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: A specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: A clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand Suppl 1959: 129: 1-35.
26. Paisey RB, Carey CM, Bower L et al. Hypertriglyceridaemia in Alström's syndrome: Causes and associations in 37 cases. Clin Endocrinol (Oxf) 2004: 60: 228-231.
27. Hearn T, Renforth GL, Spalluto C et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet 2002: 31: 79-83.
28. Green JS, Parfrey PS, Harnett JD et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 1989: 321: 1002-1009.
29. Beales P, Elcioglu N, Woolf A et al. New criteria for improved diagnosis of Bardet-Biedl syndrome: Results of a population survey. J Med Genet 1999: 36: 437-446.
30. Agarwal AK, Simha V, Oral EA et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 2003: 88: 4840-4847.